Three isoforms of the prostaglandin e receptor EP3 subtype different in agonist-independent constitutive Gi activity and agonist-dependent Gs activity
Ichikawa, A.; Negishi, M.; Hasegawa, H.
Advances in Experimental Medicine and Biology 433: 239-242
1997
ISSN/ISBN: 0065-2598
PMID: 9561144
Accession: 047779823
PDF emailed within 1 workday: $29.90
Related References
Hasegawa, H.; Negishi, M.; Ichikawa, A. 1996: Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity Journal of Biological Chemistry 271(4): 1857-1860Hasegawa, H.; Negishi, M.; Katoh, H.; Ichikawa, A. 1997: Two isoforms of prostaglandin EP3 receptor exhibiting constitutive activity and agonist-dependent activity in Rho-mediated stress fiber formation Biochemical and Biophysical Research Communications 234(3): 631-636
Negishi, M.; Hasegawa, H.; Ichikawa, A. 1996: Prostaglandin E receptor EP3gamma isoform, with mostly full constitutive Gi activity and agonist-dependent Gs activity Febs Letters 386(2-3): 165-168
Frank, C.; Molnár, F.; Matilainen, M.; Lempiäinen, H.; Carlberg, C. 2004: Agonist-dependent and agonist-independent transactivations of the human constitutive androstane receptor are modulated by specific amino acid pairs Journal of Biological Chemistry 279(32): 33558-33566
Jimenez-Cervantes, C.; Sanchez, J.; Gerritsen, I.; Hahmann, C.; Garcia-Borron, J. C. 2003: SP-02 Agonist-independent, high constitutive activity of the human melanocortin 1 receptor Pigment Cell Research 16(5): 571-572
Sánchez-Más, J.ús.; Hahmann, C.; Gerritsen, I.; García-Borrón, J.é C.; Jiménez-Cervantes, C. 2004: Agonist-independent, high constitutive activity of the human melanocortin 1 receptor Pigment Cell Research 17(4): 386-395
Tiberi, M.; Caron, M.G. 1994: High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype Journal of Biological Chemistry 269(45): 27925-27931
Yasuda, N.; Akazawa, H.; Naito, A.T.; Oka, T.; Shiojima, I.; Tamura, K.; Umemura, S.; Nemer, M.; Komuro, I.; Ito, K.; Shimizu, I.; Kudosakamoto, Y.; Yabumoto, C.; Yano, M.; Yamamoto, R.; Ozasa, Y.; Minamino, T. 2012: Agonist-Independent Constitutive Activity of Angiotensin II Receptor Promotes Cardiac Remodeling in Mice Hypertension (Dallas, Tex 1979) 59(3): 627-633
Yasuda, N.; Akazawa, H.; Ito, K.; Shimizu, I.; Kudo-Sakamoto, Y.; Yabumoto, C.; Yano, M.; Yamamoto, R.; Ozasa, Y.; Minamino, T.; Naito, A.T.; Oka, T.; Shiojima, I.; Tamura, K.; Umemura, S.; Paradis, P.; Nemer, M.; Komuro, I. 2012: Agonist-independent constitutive activity of angiotensin Ii receptor promotes cardiac remodeling in mice Hypertension 59(3): 627-633
Schwartkop, C.P.; Kreienkamp, H.J.; Richter, D. 1999: Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2 (delta349) Journal of Neurochemistry 72(3): 1275-1282
Morin, D.; Cotte, N.; Balestre, M.N.; Mouillac, B.; Manning, M.; Breton, C.; Barberis, C. 1998: The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities Febs Letters 441(3): 470-475
Negishi, M.; Sugimoto, Y.; Irie, A.; Narumiya, S.; Ichikawa, A. 1993: Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization Journal of Biological Chemistry 268(13): 9517-9521
Olli-Lähdesmäki, T.; Scheinin, M.; Pohjanoksa, K.; Kallio, J. 2003: Agonist-dependent trafficking of alpha2-adrenoceptor subtypes: dependence on receptor subtype and employed agonist European Journal of Cell Biology 82(5): 231-239
Takasuka, M.; Kishi, M.; Yamakawa, M. 1994: FTIR spectral study of intramolecular hydrogen bonding in thromboxane A2 receptor agonist (U-46619), prostaglandin (PG)E2, PGD2, PGF2 alpha, prostacyclin receptor agonist (carbacyclin), and their related compounds in dilute CCl4 solution: structure-activity relationships Journal of Medicinal Chemistry 37(1): 47-56
Chillar, A.J.; Karimi, P.; Tang, K.; Ruan, K.-H. 2011: An agonist sensitive, quick and simple cell-based signaling assay for determination of ligands mimicking prostaglandin E2 or E1 activity through subtype EP1 receptor: Suitable for high throughput screening Bmc Complementary and Alternative Medicine 11: 11
Chen, C.-R.; McLachlan, S.M.; Rapoport, B. 2007: Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity Endocrinology 148(5): 2375-2382
Schwarz, M.; Radeke, H.H.; Murphy, P.M. 2002: Dual signaling by Kaposis sarcoma-associated herpesvirus G protein-coupled receptor Agonist-independent and agonist-dependent pathways Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R77
Cohen, D.P.; Thaw, C.N.; Varma, A.; Gershengorn, M.C.; Nussenzveig, D.R. 1997: Human calcitonin receptors exhibit agonist-independent (constitutive) signaling activity Endocrinology 138(4): 1400-1405
Jin, J.; Mao, G.F.; Ashby, B. 1997: Constitutive activity of human prostaglandin E receptor EP3 isoforms British Journal of Pharmacology 121(2): 317-323
Ishikawa, M.; Shinei, R.; Yokoyama, F.; Yamauchi, M.; Oyama, M.; Okuma, K.; Nagayama, T.; Kato, K.; Kakui, N.; Sato, Y. 2010: Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice Journal of Medicinal Chemistry 53(9): 3840-3844